|
ANKRD17 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.34390009810215E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.67650021537713E-10 |
| Normal-vs-Stage2 |
3.009800E-04 |
| Normal-vs-Stage3 |
1.841550E-04 |
| Normal-vs-Stage4 |
6.808700E-04 |
| Stage1-vs-Stage2 |
3.916200E-01 |
| Stage1-vs-Stage3 |
6.428400E-01 |
| Stage1-vs-Stage4 |
8.140400E-01 |
| Stage2-vs-Stage3 |
7.407800E-01 |
| Stage2-vs-Stage4 |
7.367800E-01 |
| Stage3-vs-Stage4 |
9.535200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.32159999294879E-10 |
| Normal-vs-AfricanAmerican |
9.09280000183088E-08 |
| Normal-vs-Asian |
5.70589999999704E-05 |
| Caucasian-vs-AfricanAmerican |
8.639800E-01 |
| Caucasian-vs-Asian |
4.478800E-01 |
| AfricanAmerican-vs-Asian |
4.315200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.88260559655873E-12 |
| Normal-vs-Female |
3.782300E-04 |
| Male-vs-Female |
2.362200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.74103999999176E-05 |
| Normal-vs-Extreme_Weight |
5.11313213991116E-12 |
| Normal-vs-Obese |
9.68090000053046E-07 |
| Normal-vs-Extreme_Obese |
1.033200E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.170790E-01 |
| Normal_Weight-vs-Obese |
6.784000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.149800E-01 |
| Extreme_Weight-vs-Obese |
9.564400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.107000E-01 |
| Obese-vs-Extreme_Obese |
5.867800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.287940E-02 |
| Normal-vs-Age(41-60Yrs) |
3.4744000010356E-08 |
| Normal-vs-Age(61-80Yrs) |
1.21709975431372E-10 |
| Normal-vs-Age(81-100Yrs) |
8.36000000337123E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.084800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.486400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.106650E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.057780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.768400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.892800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.68269842504287E-11 |
| Normal-VS-Type2 PRCC |
1.65080000003037E-07 |
| Normal-VS-KIRP CIMP |
1.674780E-01 |
| Normal-VS-Unclassified PRCC |
7.419200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.780180E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.619200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.194100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.716200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.357000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.868400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.07864886098741E-12 |
| Normal-vs-N1 |
1.060450E-02 |
| Normal-vs-N2 |
1.561830E-02 |
| N0-vs-N1 |
9.274300E-02 |
| N0-vs-N2 |
4.678800E-01 |
| N1-vs-N2 |
7.642800E-01 |
|
|
